Payment overview · 2025
General Payments
$15.20
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert Mormando, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · PORT JEFFERSON STATION, NY · NPI 1306816129
Verified facts
What the public records show
CMS Open Payments records show Robert Mormando, D.O. received $15.20 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.20 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.20 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 592 | 167 |
| Atorvastatin Calcium | Atorvastatin Calcium | 587 | 177 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 586 | 173 |
| Amlodipine Besylate | Amlodipine Besylate | 472 | 143 |
| Omeprazole | Omeprazole | 388 | 112 |
| Metoprolol Succinate | Metoprolol Succinate | 331 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 264 | 79 |
| Alprazolam | Alprazolam | 246 | 67 |
| Ramipril | Ramipril | 208 | 60 |
| Duloxetine Hcl | Duloxetine Hcl | 207 | 66 |
| Gabapentin | Gabapentin | 203 | 71 |
| Losartan Potassium | Losartan Potassium | 194 | 60 |
| Mounjaro | Tirzepatide | 186 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 180 | 31 |
| Lisinopril | Lisinopril | 176 | 51 |
| Jardiance | Empagliflozin | 175 | 40 |
| Eliquis | Apixaban | 170 | 48 |
| Meloxicam | Meloxicam | 167 | 45 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 163 | 42 |
| Montelukast Sodium | Montelukast Sodium | 163 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 153 | 51 |
| Carvedilol | Carvedilol | 148 | 44 |
| Oxycodone Hcl | Oxycodone Hcl | 147 | 22 |
| Finasteride | Finasteride | 138 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 132 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 130 | 40 |
| Furosemide | Furosemide | 116 | 32 |
| Metformin Hcl Er | Metformin Hcl | 116 | 33 |
| Ezetimibe | Ezetimibe | 111 | 31 |
| Trazodone Hcl | Trazodone Hcl | 111 | 35 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 102 | 32 |
| Bupropion Xl | Bupropion Hcl | 102 | 35 |
| Synthroid | Levothyroxine Sodium | 99 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 95 | 34 |
| Allopurinol | Allopurinol | 94 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 28 |
| Famotidine | Famotidine | 83 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 80 | 33 |
| Sertraline Hcl | Sertraline Hcl | 78 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 76 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 72 | 18 |
| Benazepril Hcl | Benazepril Hcl | 70 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 70 | suppressed |
| Wegovy | Semaglutide | 70 | 15 |
| Irbesartan | Irbesartan | 69 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 67 | 13 |
| Rybelsus | Semaglutide | 64 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 62 | 31 |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 60 | suppressed |
| Simvastatin | Simvastatin | 58 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 57 | 14 |
| Potassium Chloride | Potassium Chloride | 57 | 21 |
| Pregabalin | Pregabalin | 57 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 55 | 14 |
| Topiramate | Topiramate | 54 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 51 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 51 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 29 |
| Prednisone | Prednisone | 47 | 29 |
| Lidocaine | Lidocaine | 46 | suppressed |
| Xarelto | Rivaroxaban | 46 | 12 |
| Januvia | Sitagliptin Phosphate | 45 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 45 | 40 |
| Clonazepam | Clonazepam | 44 | suppressed |
| Ozempic | Semaglutide | 44 | 13 |
| Farxiga | Dapagliflozin Propanediol | 43 | 13 |
| Metformin Hcl | Metformin Hcl | 43 | 17 |
| Entresto | Sacubitril/Valsartan | 41 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 40 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 40 | 11 |
| Methocarbamol | Methocarbamol | 40 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 38 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | 12 |
| Linzess | Linaclotide | 36 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 35 | 12 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 34 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 34 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 33 | suppressed |
| Dutasteride | Dutasteride | 33 | suppressed |
| Eszopiclone | Eszopiclone | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 33 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 33 | suppressed |
| Spironolactone | Spironolactone | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 33 | 11 |
| Mometasone Furoate | Mometasone Furoate | 32 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 32 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 28 |
| Valacyclovir | Valacyclovir Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 29 | 11 |
| Famciclovir | Famciclovir | 28 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 27 | suppressed |
| Fentanyl | Fentanyl | 27 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 27 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 26 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Ketoconazole | Ketoconazole | 25 | 11 |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Amoxicillin | Amoxicillin | 24 | 15 |
| Valsartan | Valsartan | 24 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Atenolol | Atenolol | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Nystatin | Nystatin | 22 | suppressed |
| Telmisartan | Telmisartan | 22 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Epinephrine | Epinephrine | 20 | suppressed |
| Eplerenone | Eplerenone | 20 | suppressed |
| Oxycontin | Oxycodone Hcl | 20 | suppressed |
| Tadalafil | Tadalafil | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 19 | suppressed |
| Testosterone | Testosterone | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 14 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 17 | suppressed |
| Isentress Hd | Raltegravir Potassium | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Pifeltro | Doravirine | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 13 | suppressed |
| Fluocinonide | Fluocinonide | 13 | suppressed |
| Livalo | Pitavastatin Calcium | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Procto-Med Hc | Hydrocortisone | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Skyclarys | Omaveloxolone | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Zaleplon | Zaleplon | 13 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Mirtazapine | Mirtazapine | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Xanax | Alprazolam | 12 | suppressed |
| Alprazolam Er | Alprazolam | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.20 · 1 records | Amgen Inc. | REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error